| Literature DB >> 19128188 |
Sylvain Broussy1, Ross W Cheloha, David B Berkowitz.
Abstract
The use of NADH- and NADPH-dependent ketoreductases to access enantioenriched pharmaceutical building blocks is reported. Seven structurally diverse synthons are obtained, including those for atomoxetine (KRED 132), talampanel (RS1-ADH and CPADH), Dolastatin (KRED 132), and fluoxetine (KRED 108/132). Ethanol may be used as stoichiometric reductant, regenerating both nicotinamide cofactors, particularly under four-electron redox conditions. Its favorable thermodynamic and economic profile, coupled with its advantageous dual cosolvent role, suggests a new application for biomass-derived ethanol.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19128188 PMCID: PMC6027600 DOI: 10.1021/ol802464g
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005